Position in BHVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,692,072
+$6,709,034 QoQ
Shares Held
651,349
+84.7% QoQ
Ownership
0.431%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 294 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. BHVN ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in BHVN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,692,072 | 651,349 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,983,038 | 352,605 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $339,004 | 30,027 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $372,206 | 26,379 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,626,489 | 234,047 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $13,703,377 | 366,891 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $18,572,299 | 371,669 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $3,664,265 | 105,568 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $42,838,239 | 783,292 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $16,628,527 | 388,517 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $32,013,523 | 1,230,816 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $25,977,430 | 1,086,013 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $21,914,027 | 1,604,248 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $29,949,805 | 2,157,767 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $7,928,016 | 1,287,350 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||